Literature DB >> 30508334

Synthesis and Cytotoxic Evaluation of Artemisinin-triazole Hybrids.

Doan Duy Tien, Le Nhat Thuy Giang, Dang Thi Tuyet Anh, Nguyen Tien Dung, Thanh Nguyen Ha, Nguyen Thi Thu Ha, Hoang Thi Phuong, Pham The Chinh, Phan Van Kiem, Nguyen Van Tuyen.   

Abstract

Dihydroartemisinin was converted to its corresponding alkyne-functionalized esters, which were subsequently deployed as substrates for a 'click' chemistry-mediated coupling-with 3'-azido-3'-deoxythydimine (AZT) to furnish novel triazole-artesunate-AZT hybrid compounds. Moreover, various substituted triazole-artemisinin :hybrids were synthesized based on 'click' chemistry between propargyl-substituted derivatives and artemisinin containing a 2-hydroxypropane unit. Fourteen new hybrids were thus successfully prepared and evaluated as cytotoxic agents, revealing an interesting anticancer activity of four triazole-artemisinin derivative hybrids in KB and HepG2 cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 30508334

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  3 in total

Review 1.  Semisynthetic Derivatives of Pentacyclic Triterpenes Bearing Heterocyclic Moieties with Therapeutic Potential.

Authors:  Gabriela Nistor; Cristina Trandafirescu; Alexandra Prodea; Andreea Milan; Andreea Cristea; Roxana Ghiulai; Roxana Racoviceanu; Alexandra Mioc; Marius Mioc; Viviana Ivan; Codruța Șoica
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

2.  N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity.

Authors:  Mahboubeh Varmazyad; Mira M Modi; Amanda L Kalen; Ehab H Sarsour; Brett Wagner; Juan Du; Michael K Schultz; Garry R Buettner; F Christopher Pigge; Prabhat C Goswami
Journal:  Free Radic Biol Med       Date:  2021-02-06       Impact factor: 8.101

Review 3.  Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.

Authors:  Sijongesonke Peter; Siphesihle Jama; Sibusiso Alven; Blessing A Aderibigbe
Journal:  Molecules       Date:  2021-12-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.